Why Mouse Liver Cells Resist Hepatitis E Virus

Researchers have identified the genetic mechanism that prevents mouse liver cells from being infected by the hepatitis E virus (HEV), according to a report by News-Medical on July 29, 2026. The discovery explains why mice have historically resisted the virus and provides a potential pathway for developing new antiviral therapies for human patients.

Hepatitis E is a liver infection caused by the HEV virus, typically transmitted through contaminated water or the consumption of undercooked pork and deer meat. While the virus affects humans and pigs, mouse liver cells have remained naturally resistant to infection, a fact that has long hindered the use of mice as animal models for studying the disease.

The Genetic Basis of Mouse Liver Resistance

The study detailed by News-Medical indicates that the resistance in mouse liver cells is tied to specific genetic differences in how the cells interact with the virus. The research identifies that the virus fails to enter or replicate within mouse hepatocytes because the mouse version of certain cellular receptors or proteins does not align with the requirements of the HEV virus.

In humans, the virus utilizes specific surface proteins to attach to and enter liver cells. The findings suggest that the mouse genome lacks the specific molecular “lock” that the HEV “key” requires to gain entry. This genetic divergence ensures that the mouse liver remains an inhospitable environment for the virus, preventing the onset of hepatitis.

Impact on Hepatitis E Research and Modeling

The inability to infect mice with HEV has created a gap in virology, as mice are the most common subjects for genetic engineering and drug testing. According to the News-Medical report, understanding the exact reason for this resistance allows scientists to potentially “humanize” mouse liver cells. By introducing the human genetic sequences that the virus targets, researchers can create susceptible mouse models to test vaccine efficacy and antiviral drugs in a living system.

This development is particularly significant for the study of chronic hepatitis E. While many human infections are acute and resolve on their own, some patients—particularly those with pre-existing liver conditions—develop chronic infections that lead to cirrhosis. The ability to model this progression in mice could accelerate the discovery of treatments for long-term HEV infections.

Transmission Risks and Viral Behavior

The research underscores the zoonotic nature of the virus. HEV is known to jump from animals to humans, primarily through the consumption of infected meat. Because pigs are highly susceptible and act as a reservoir for the virus, the contrast between the pig’s susceptibility and the mouse’s resistance highlights the specific evolutionary adaptations the virus has made to target certain mammalian liver cells.

Public health guidelines generally emphasize the importance of cooking meat to safe internal temperatures to neutralize the virus. The molecular insights gained from the mouse study may eventually lead to therapies that mimic the mouse’s natural resistance, effectively blocking the virus from entering human liver cells.

Future Therapeutic Directions

By pinpointing the genetic barrier in mice, scientists can now investigate whether similar barriers can be artificially induced in human cells. If the specific protein interaction that blocks the virus in mice can be replicated or simulated using synthetic molecules, it could lead to a new class of entry-inhibitor drugs.

Current treatment for hepatitis E often relies on supportive care or, in severe chronic cases, the use of ribavirin. The discovery of the mouse’s resistance mechanism provides a new biological blueprint for interventions that stop the virus before it ever penetrates the cell membrane, rather than attempting to stop replication after the infection has already begun.